Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Lisinopril and Hydrochlorothiazide TabletsRevised: March 2009Rx only 184007
Medication labelWhy this: Advisory · dailymed-prescription
Lisinopril and hydrochlorothiazide tablets are indicated for the treatment of hypertension. These fixed-dose combinations are not indicated for initial therapy (see DOSAGE AND ADMINISTRATION ). In using lisinopril and hydrochlorothiazide tablets, consideration should be given to the fact that an angiotensin-converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen vascular disease, and that available data are insufficient to show that lisinopril does not have a similar risk. (See WARNINGS .) In considering use of lisinopril and hydrochlorothiazide tablets, it should be noted that ACE inhibitors have been associated with a higher rate of angioedema in black than in nonblack patients. (See WARNINGS , Lisinopril .)
- generic_name
- lisinopril and hydrochlorothiazide
- product_names
- Lisinopril and hydrochlorothiazide
- ndc
- 21695-733, 0591-0860, 21695-733-30, 21695-734, 0591-0861, 21695-734-30, 21695-735, 0591-0862, 21695-735-30
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en